NO307612B1 - Fremgangsmåte for fremstilling av en vevstypeplasminogen- aktivatorvariant - Google Patents

Fremgangsmåte for fremstilling av en vevstypeplasminogen- aktivatorvariant

Info

Publication number
NO307612B1
NO307612B1 NO901995A NO901995A NO307612B1 NO 307612 B1 NO307612 B1 NO 307612B1 NO 901995 A NO901995 A NO 901995A NO 901995 A NO901995 A NO 901995A NO 307612 B1 NO307612 B1 NO 307612B1
Authority
NO
Norway
Prior art keywords
plasminogen activator
type plasminogen
preparing
tissue type
activator variant
Prior art date
Application number
NO901995A
Other languages
English (en)
Norwegian (no)
Other versions
NO901995L (no
NO901995D0 (no
Inventor
Adair J Hotchkiss
John V O'connor
Michael W Spellman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NO901995D0 publication Critical patent/NO901995D0/no
Publication of NO901995L publication Critical patent/NO901995L/no
Publication of NO307612B1 publication Critical patent/NO307612B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO901995A 1987-11-06 1990-05-04 Fremgangsmåte for fremstilling av en vevstypeplasminogen- aktivatorvariant NO307612B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11809887A 1987-11-06 1987-11-06
PCT/US1988/003901 WO1989004368A1 (en) 1987-11-06 1988-11-02 Novel human tissue-type plasminogen activator variant

Publications (3)

Publication Number Publication Date
NO901995D0 NO901995D0 (no) 1990-05-04
NO901995L NO901995L (no) 1990-07-05
NO307612B1 true NO307612B1 (no) 2000-05-02

Family

ID=22376492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901995A NO307612B1 (no) 1987-11-06 1990-05-04 Fremgangsmåte for fremstilling av en vevstypeplasminogen- aktivatorvariant

Country Status (18)

Country Link
EP (2) EP0754753A1 (da)
JP (1) JPH03500843A (da)
KR (1) KR920009521B1 (da)
AT (1) ATE151812T1 (da)
AU (2) AU2804989A (da)
CA (1) CA1341609C (da)
DD (1) DD286613A5 (da)
DE (1) DE3855874T2 (da)
DK (1) DK175482B1 (da)
FI (1) FI102970B (da)
HU (1) HU215230B (da)
IL (1) IL88247A0 (da)
NO (1) NO307612B1 (da)
NZ (1) NZ226829A (da)
PH (1) PH30064A (da)
PT (1) PT88938B (da)
WO (1) WO1989004368A1 (da)
ZA (1) ZA888250B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246850A (en) * 1990-07-31 1993-09-21 Genentech, Inc. DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells
DE69113049T2 (de) * 1990-07-31 1996-04-04 Genentech, Inc., South San Francisco, Calif. Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
JP3559559B2 (ja) 1992-06-03 2004-09-02 ジェネンテク，インコーポレイテッド 向上した治療特性を有する組織プラスミノーゲン活性化因子グリコシル化変異体
DE69719265T2 (de) * 1996-09-06 2003-12-04 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute, Kumamoto Medizinische Zusammensetzung die Gewebeplasminogenaktivator und Nikotinamid enthält
US7084118B2 (en) 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin
WO2025262265A1 (en) 2024-06-21 2025-12-26 Etablissement Francais Du Sang Chimeric molecules comprising an anti-fibrin antibody and an antithrombotic molecule

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125254A1 (en) * 1982-10-28 1984-11-21 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
WO1987004722A1 (en) * 1986-01-31 1987-08-13 Genetics Institute, Inc. Novel thrombolytic proteins
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same
EP0311589B1 (en) * 1987-10-09 1994-03-23 Monsanto Company Modified tissue plasminogen activator

Also Published As

Publication number Publication date
EP0387290B1 (en) 1997-04-16
IL88247A0 (en) 1989-06-30
DE3855874T2 (de) 1997-09-11
FI102970B1 (fi) 1999-03-31
PT88938A (pt) 1989-11-30
CA1341609C (en) 2011-02-01
DK112290D0 (da) 1990-05-04
AU2131792A (en) 1992-11-19
DD286613A5 (de) 1991-01-31
ATE151812T1 (de) 1997-05-15
EP0754753A1 (en) 1997-01-22
KR920009521B1 (ko) 1992-10-17
AU2804989A (en) 1989-06-01
DE3855874D1 (de) 1997-05-22
HUT54209A (en) 1991-01-28
AU658909B2 (en) 1995-05-04
DK175482B1 (da) 2004-11-08
EP0387290A1 (en) 1990-09-19
HU215230B (hu) 2000-03-28
ZA888250B (en) 1990-07-25
JPH03500843A (ja) 1991-02-28
PT88938B (pt) 1993-05-31
FI902239A0 (fi) 1990-05-04
FI102970B (fi) 1999-03-31
KR890701733A (ko) 1989-12-21
NO901995L (no) 1990-07-05
DK112290A (da) 1990-07-06
HU890157D0 (en) 1990-12-28
PH30064A (en) 1996-11-08
NO901995D0 (no) 1990-05-04
WO1989004368A1 (en) 1989-05-18
NZ226829A (en) 1991-06-25

Similar Documents

Publication Publication Date Title
DE3751842D1 (de) Modifizierter, menschlicher Gewebeplasminogenaktivator und seine Herstellung
IL80659A (en) Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them
DE69003253D1 (de) Enzymhaltige zubereitung und eine solche zubereitung enthaltendes detergens.
EP0233013A3 (en) Modified enzyme
HUT43877A (en) Tissue plasminogen activator (tpa) derivative and process for preparing the same
DK96787A (da) Human vaevs-plasminogenaktivator
DK112290A (da) Vaevsplasminogenaktivator-variant
FI873060A7 (fi) Modifioitu kudosplasmiiniaktivaattori.
NO168055C (no) Fremgangsmaate for fremstilling av human vevplasminogenaktivator og urokinase-type plasminogenaktivator.
FI902700A0 (fi) Vaevnadplasminogenaktivatorderivat.
Sullivan Application of supported enzymes in clinical chemistry.
IL109759A0 (en) Human tissue-type plasminogen activator having modified functional carbohydrate residues, which retains its biological activity and is characterized by an increased in vivo half-life
IE870208L (en) Modified tissue plasminogen activator
IE871856L (en) "modified tissue plasminogen activator"

Legal Events

Date Code Title Description
MK1K Patent expired